Novel geldanamycin derivative, 4,5-dihydro-thiazinogeldanamycin (3), was characterized from the gdmP mutant in Streptomyces hygroscopicus 17997, besides expected 4,5-dihydro-geldanamycin (2). The presence of this compound would suggest an unknown post-PKS modification in geldanamycin biosynthesis. Compound 3 exhibited moderate anti-HSV-1-virus activity and higher water solubility than geldanamycin (1). Cysteine served as a precursor to synthesize 3, whose formation required obligatory enzymatic assistance.
Geldanamycin (1) is a promising anticancer agent because it can inhibit the chaperone activity of heat shock protein 90 (Hsp90) which is critical for the maturation and activation of a number of proteins involved in carcinogenesis and tumor development. 1) However, its hepatotoxicity and low water solubility have limited its further clinical development.
2) A geldanamycin derivative, 17-allylamino-17-demethoxygeldanamycin (17-AAG), is currently undergoing phase II clinical trials.
3) Notwithstanding its improved pharmacological properties, 17-AAG with limited aqueous solubility cannot supply the optimal dosing regimen to patients. The development of novel geldanamycin analogues with better water solubility is therefore currently in high demand.
The biosynthesis of 1 is started by assembling AHBA, 4) followed by the sequential addition of such extender units as malonyl-CoA, 2-methoxymalonylCoA and 2-methylmalonyl-CoA to form a polyketide backbone, and then post-PKS modification steps of C-17 hydroxylation, C-17-O-methylation, C-21 oxidation, C-7 carbamoylation, and C-4,5 oxidation, 5, 6) although the genes responsible for these modifications have not yet been totally elucidated. For example, the genes involved in C-17 hydroxylation and C-21 oxidation have still not been precisely assigned, although gdmM is considered to be involved in one of these post-PKS oxidation steps. 7) We report here the finding, structural elucidation and biological properties, as well as a preliminary study on the formation of 4,5-dihydrothiazinogeldanamycin (3) in gdmP-engineered S. hygroscopicus 17997.
GdmP gene was homologous to cytochrome P450 monooxygenase and responsible for C-4,5 oxidation in geldanamycin biosynthesis. 8) GdmP was inactivated in S. hygroscopicus 17997 by inserting a kanamycinresistant gene (Km R ) through conjugation and doublecrossover homologous recombination. 9) Recombinants containing Km R were confirmed by PCR and southern blotting, using their total genomic DNA as templates. The gdmP disruption mutant (ÁgdmP) was complemented by expressing the intact gdmP gene under the ermE promoter in trans form. The complementary strain showed the phenotype of apramycin resistance (Am R ) and was confirmed by PCR.
A wild-type strain, ÁgdmP, and complementary strain were grown in 50 mL of a fermentation medium (20 g of starch, 5 g of cotton seed flour, 5 g of glucose, 10 g of corn syrup, 5 g of yeast extract, and 2 g of CaCO 3 , each per liter) and incubated at 28 C for five days. The fermentation broth was extracted with EtOAc, and HPLC was carried out with an LC-10A instrument (Shimadzu, Japan). The compounds were detected with a Diamonsil C18 column (Dikma, China; 5.0 mm, 4:6 Â 150 mm) eluted with a gradient of 40-100% MeOH/H 2 O for 40 min at rate of 1 mL/min. Compared with the wild-type strain, ÁgdmP had completely lost its ability to produce mature geldanamycin; instead, two major metabolites with retention times (Rts) of 13.1 min and 29.5 min, were detected. Geldanamycin production could be partly restored in the gdmP complementary strain. The compound with Rt 29.5 min was easily identified to be 4,5-dihydro-geldanamycin (2) by LC-MS data (½M þ Na þ , m=z 585) and the UV absorbance spectrum according to ref. 10, this being consistent with the results by inactivating gel16 (identical to gdmP) in another geldanamycin producer. 8) However, the emergence of other compound with Rt 13.1 min (3) was * These authors equally contributed to this work. C. The UV spectrum of 3 showed a strong absorption at 250 nm. The IR data displayed absorption signals at 3288 and 3572 cm À1 characteristic of amines and hydroxyl functionalities, carbonyl stretches being evident at 1741, 1716 and 1661 cm À1 . The molecular weight of 3 was suggested to be 635 from the ESI-MS peak at m=z 634 ½M À H À (LTQ Orbitrap XL, Thermo Scientific, USA), and one sulfur atom was confirmed by an elemental analysis (4.87%). Compound 3 was assigned the molecular formula of C 31 H 45 N 3 O 9 S on the basis of its HRFABMS (m=z calcd. for 658.2774 ½M þ Na þ ; found 658.2758 ½M þ Na þ (LTQ Orbitrap XL, Thermo Scientific).
The NMR spectra data for 3 were measured in DMSO-d 6 at a temperature of 75 C (Table 1) . There were some differences between the NMR data for 3 and 1.
11) Firstly, no signals for C-4 and C-5 (the two olefinic carbons) in compound 1 were detectable in compound 3, suggested that this cis double bond had been reduced as expected. Secondly, a proton resonance for H-19 was absent, an active proton signal ( H 9.14) emerging. Thirdly, the respective upshift of C-18 and C-21 (120.62 and 147.53 ppm) indicated the absence of the benzoquinone moiety, although there may have been a phenolic hydroxyl group, this being supported by the positive color reaction with ferric chloride, and this phenolic hydroxyl group should be attached to C-21 in accordance with its chemical shift. Finally, there were two new carbon signals at 163.92 and 29.45 ppm, these being assigned to methylene and carbonyl functionalities. A combination of COSY, HSQC, HMBC, NOESY data was used to unambiguously assign the 1 H-and 13 C-NMR data. The HMBC spectrum exhibited cross-peaks from an amide proton ( H 9.14) to C-17, -18, -19, -22 and -23. Selective NOESY experiments showed that irradiation of 17-OCH 3 at H 3.63 resulted in enhancement of the signal at 9.14, implying the linkage of -NHwith the benzoquinone moiety at C-18. The chemical shift of -NH-was up to 9.14, indicating that it was directly attached to the carbonyl (C-23) adjacent to C-22. The large spin coupling constant (15 Hz) between the methylene protons (22-2H) suggested that this methylene was involved in a cyclic structure. The 2H signals ( H 3.22/3.56) of C-22 were also constantly coupled with C-19 and C-23 in the HMBC spectra, indicating that C-22 was connected to C-19 through a sulfide bond. The UV, IR and MS data with the NMR spectrum elucidated the structure of this new metabolite, 4,5-dihydro-thiazinogeldanamycin (3), to be that shown in Fig. 1 . Compound 3 is not the first thiazino-ansamycin to be identified as being produced by microorganisms; ansathiazin, thiazinotrienomycins and thiazorifamycins have also been reported. [12] [13] [14] [15] However, very little has been known until recently about the biosynthetic process for the thiazino-moiety. The cysteine could serve as a precursor to be involved in the thiazino-moiety biosynthesis of thiazorifamycins. 15) A bioconversion experiment was therefore performed, using a geldanamycinpks mutant strain, to make a preliminary study on the biosynthesis of 3. The mutant strain was unable to produce compound 1, but it retained a full complement of post-PKS processing genes, and its washed mycelia were prepared by starving under incubation with a phosphate buffer. The prepared mycelia could effectively convert compound 2 to compound 3 in the presence of cysteine, while no compound 3 could be detected in parallel groups without cysteine or the mycelia (Fig. 2) . The bioconversion results indicated cysteine to be a precursor in the biosynthesis of the thiazino-moiety of 3, and the process required obligatory enzymatic assistance.
The bioactivity against the HSV-1 virus and the water solubility of the geldanamycin analogs were assessed as previously described. 16 ) Compound 3 exhibited moderate anti-HSV-1-virus activity toward infected VERO cells with an IC 50 value of 0.252 mmol/L, vs. 0.146 mmol/L for compound 1 and 3.149 mmol/L for compound 2. However, the water solubility of 3 was 0.573 mg/mL, approximately 33-fold higher than that of 1 (0.017 mg/mL), and 9-fold higher than that of 2 (0.058 mg/mL).
In summary, genetic engineering provided two geldanamycin analogues, 2 and novel sulfur-containing metabolite 3, which suggests that a C19-sulfur modification step may be involved in the post-PKS pathway of 1. The obtained novel metabolite had water solubility almost 33-fold higher than compound 1, with an additional thiazino-moiety in the hydroquinone ring which was difficult to achieve sole by a chemical reaction. 
